Literature DB >> 7306435

Withdrawal of long-term therapy with atenolol in hypertensive patients.

J Webster, G M Hawksworth, H E Barber, T A Jeffers, J C Petrie.   

Abstract

1 The offset of effects on blood pressure and heart rate after cessation of long-term therapy (19 +/- 3.6 months) with atenolol (200 mg once/daily) was studied in six hypertensive patients. 2 Withdrawal of atenolol resulted in a gradual return of lying, standing and post-exercise systolic and diastolic blood pressure levels and heart rate towards the baseline value. The offset of effect greatly exceeded the time for elimination of atenolol. 3 No significant differences in the pharmacokinetic profile of atenolol were evident between the values obtained following chronic dosing and an acute single-dose study. 4 The lack of clinical evidence of increased cardiac adrenergic sensitivity or rebound hypertension following withdrawal of atenolol contrasts with reports of a withdrawal syndrome following cessation of therapy with propranolol. Nevertheless until the mechanism of the propranolol-withdrawal syndrome is better understood caution is required when stopped therapy with atenolol in patients with severe coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306435      PMCID: PMC1401869          DOI: 10.1111/j.1365-2125.1981.tb01202.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Atenolol and metoprolol in mild hypertension.

Authors:  T A Jeffers; J Webster; B Reid; J C Petrie; N P Barker
Journal:  Br Med J       Date:  1978-11-04

2.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

3.  Atenolol and bendrofluazide in hypertension.

Authors:  J C Petrie; D B Galloway; J Webster; W T Simpson; J A Lewis
Journal:  Br Med J       Date:  1975-10-18

4.  The gas chromatographic determination of atenolol in biological samples.

Authors:  B Scales; P B Copsey
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

5.  Catecholamines in coronary sinus during exercise in man before and after training.

Authors:  D Cousineau; R J Ferguson; J de Champlain; P Gauthier; P Côté; M Bourassa
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-11

6.  Mechanism of propranolol withdrawal phenomena.

Authors:  S Nattel; R E Rangno; G Van Loon
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

7.  Determinants of coronary sinus noradrenaline in patients with ischaemic heart disease: coronary sinus catecholamine concentration in relation to arterial catecholamine concentration, pulmonary artery oxygen saturation and left ventricular end-diastolic pressure.

Authors:  J F Hansen; N J Christensen; B Hesse
Journal:  Cardiovasc Res       Date:  1978-07       Impact factor: 10.787

  7 in total
  4 in total

1.  Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.

Authors:  O J Robb; J Webster; J C Petrie; J D Harry; J Young
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

2.  Beta blockers for elective surgery in elderly patients: population based, retrospective cohort study.

Authors:  Donald Redelmeier; Damon Scales; Alexander Kopp
Journal:  BMJ       Date:  2005-10-06

3.  Atenolol disposition in young and elderly subjects.

Authors:  P C Rubin; P J Scott; K McLean; A Pearson; D Ross; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 4.  Withdrawal of antihypertensive therapy in the elderly. The issues.

Authors:  M D Fotherby
Journal:  Drugs Aging       Date:  1995-06       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.